TTNP
Titan Pharmaceuticals
TTNP
TTNP
Delisted
TTNP was delisted on the 1st of October, 2025.
18 hedge funds and large institutions have $1.24M invested in Titan Pharmaceuticals in 2022 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 3 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
18
Holders Change
–
Holders Change %
0%
% of All Funds
0.28%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
4
Reduced
3
Closed
3
Calls
$13K
Puts
–
Net Calls
+$13K
Net Calls Change
-$70K
Top Buyers
1 |
AC
Armistice Capital
New York
|
+$826K |
2 |
Barclays
London,
United Kingdom
|
+$48K |
3 |
Renaissance Technologies
New York
|
+$16.3K |
4 |
![]()
Group One Trading
Chicago,
Illinois
|
+$13.4K |
5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$9.9K |
Top Sellers
1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$40K |
2 |
VF
Virtu Financial
New York
|
-$16K |
3 |
WPA
Winning Points Advisors
Boca Raton,
Florida
|
-$15K |
4 |
Millennium Management
New York
|
-$9.71K |